We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Next Generation Bone Graft Delivery System Resolves Unique Challenges of Minimally Invasive Spinal Surgery

By HospiMedica International staff writers
Posted on 04 Mar 2022

A next generation minimally invasive bone graft delivery system utilizes a pre-loaded bone graft cannula and a streamlined trigger-based system as a bone graft delivery solution that is optimized for the unique challenges of minimally invasive surgery. More...

Synergy Biomedical, LLC (Wayne, PA, USA) has launched the BIOSPHERE MIS II system which permits strategic and controlled placement of the company’s regarded next-generation synthetic bone graft product (BIOSPHERE PUTTY) in open, mini-open, and percutaneous minimally invasive settings. BIOSPHERE MIS II PUTTY utilizes patented bioactive glass spheres that have been shown in vivo to result in faster and more robust bone formation. The product provides surgeons with a moldable bone graft material that has one of the highest bioactive glass contents on the market.

The BIOSPHERE MIS II bone graft delivery system consists of several new innovative features such as a new hand-held dispenser, an upgraded trigger configuration, and a graft delivery cannula, pre-loaded with BIOSPHERE PUTTY. Design advances with BIOSPHERE MIS II include a new locking technology that provides audible and tactile confirmation for a secure locked connection between the cannula and dispenser. A low-profile system maximizes the surgeons’ view during graft delivery around implanted hardware and difficult to access anatomic locations. An enhanced trigger design provides surgeons with full control of BIOSPHERE PUTTY delivery volume and location. The BIOSPHERE MIS II system is a uniquely designed two-piece assembly specifically engineered for increasing efficiency in the OR.

“BIOSPHERE MIS II is a low-profile graft delivery system that allows me to place graft in difficult to access locations without obstructing my view. My favorite feature is being able to control the amount of graft that is delivered by simply deploying the trigger handle,” stated Dr. Barcohana, M.D., a spine surgeon at the Southern California Orthopedic Institute in alliance with UCLA Health). “MIS II is a Next Generation System that provides me with the solutions I need when facing the unique challenges of minimally invasive spinal surgery.”

Related Links:
Synergy Biomedical, LLC 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.